Status | Study |
Completed |
Study Name: Assessment of the Immunogenicity and Safety of a Dose-Sparing BioThrax® AVA Schedule Condition: Bacillus Anthracis (Anthrax) Date: 2012-07-05 Interventions: Biological: BioThrax® Bio |
Suspended |
Study Name: A Study to Assess Dose-Response, Efficacy (Immunogenicity) and the Safety of GC1109 Condition: Anthrax Date: 2012-03-06 Interventions: Biological: rPA vaccine containing alhydrogel 1.0 mL |
Completed |
Study Name: Immunogenicity and Safety Study of a Three-Dose BioThrax® Regimen for Post-Exposure Prophylaxis in Healthy Adults Condition: Anthrax Date: 2011-12-12 Interventions: Biological: BioThrax BioThrax, 0.5 mL administered subcutaneously on days 0, 14, and 28. |
Completed |
Study Name: Placebo-Controlled, Sequential Group, Single Dose, Dose-Escalation Study to Evaluate the Safety and PK of ETI-204 Condition: Anthrax Date: 2011-10-14 Interventions: Drug: ETI-204, "Anthim" |
Completed |
Study Name: Glyburide Advantage in Malignant Edema and Stroke Pilot Condition: Ischemic Stroke Date: 2010-12-29 Interventions: Drug: RP-1127 (Glyburide for injection) Bolus plus 72 hour IV infusion |
Completed |
Study Name: Safety, Tolerability and Immunogenicity Study of AV7909 Anthrax Vaccine in Healthy Adults Condition: Bacillus Anthracis (Anthrax) Infection Date: 2010-12-17 Interventions: Biological: BioThrax BioThrax |
Completed |
Study Name: Dose Escalation Study of Valortim® (MDX-1303) Administered Intravenously (IV) in Healthy, Normal Subjects Condition: Anthrax Date: 2010-12-17 Interventions: Drug: Normal Saline for Injection |
Completed |
Study Name: Safety and Pharmacokinetics Study of Human Monoclonal Antibody (AVP-21D9) Condition: Anthrax Date: 2010-09-13 Interventions: Drug: AVP-21D9 intravenously, |
Terminated |
Study Name: Ph1 Study of Valortim and Doxycycline in Humans Condition: Anthrax Date: 2009-08-24 Interventions: Drug: Doxycycline and Valortim |
Suspended |
Study Name: Ph1 Study of Valortim and Ciprofloxacin in Humans Condition: Anthrax Date: 2009-08-22 Interventions: Drug: Ciprofloxacin and Valortim |